米国株 ファンダメンタル分析US Fundamental Analysis
📋 ソース: VCP/Stage 2
📋 Source: VCP/Stage 2
| RS Rating | 83.0 |
| Minervini Score | 10/10 |
| CANSLIM Score | 7/10 |
| EPS Growth | 10.5% |
| Revenue Growth | -1.7% |
| ROE | 20.3% |
| Sector | Healthcare |
📋 ソース: VCP/Stage 2
📋 Source: VCP/Stage 2
| RS Rating | 83.0 |
| Minervini Score | 10/10 |
| CANSLIM Score | 7/10 |
| EPS Growth | 10.5% |
| Revenue Growth | -1.7% |
| ROE | 20.3% |
| Sector | Healthcare |